PPA
GBIO

Parametric Portfolio Associates’s Generation Bio GBIO Stock Holding History

Parametric Portfolio Associates’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$128K Buy
1,745
+717
+70% +$41.5K ﹤0.01% 3524
2021
Q4 		$73K Sell
1,028
-170
-14% -$29.7K ﹤0.01% 3581
2021
Q3 		$300K Sell
1,198
-78
-6% -$18.7K ﹤0.01% 3306
2021
Q2 		$343K Buy
1,276
+239
+23% +$71.5K ﹤0.01% 3227
2021
Q1 		$295K Buy
+1,037
New +$332K ﹤0.01% 3723

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return

Parametric Portfolio Associates's GBIO Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Generation Bio (GBIO) stake by 70% in Q1 2022, buying an estimated $41.5K and bringing the position to 1,745 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #3524.

Parametric Portfolio Associates first reported a position in GBIO in Q1 2021 and has held it in 5 quarters since. The position peaked at $343K in Q2 2021. 88 funds tracked by Wall St. Rank hold GBIO as of Q1 2022.

  • Parametric Portfolio Associates held 1,745 shares of Generation Bio worth $128K as of Q1 2022.
  • Parametric Portfolio Associates bought 717 Generation Bio shares in Q1 2022, an estimated $41.5K.
  • Generation Bio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3524 holding.
  • Parametric Portfolio Associates first reported a position in Generation Bio in Q1 2021 and has held it in 5 quarters since.
  • Parametric Portfolio Associates's Generation Bio position peaked at $343K in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Generation Bio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.